Glecaprevir/pibrentasvir+sofosbuvir: an optimal retreatment strategy in the setting of HCV NS5A resistance
Alimohammadi, Arshia, Conway, Brian, Yamamoto, LeoVolume:
13
Journal:
BMJ Case Reports
DOI:
10.1136/bcr-2019-233098
Date:
February, 2020
File:
PDF, 266 KB
2020